Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 5c
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.45), $0.05 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.
